NCT00581425View on ClinicalTrials.gov

Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)

PHASE4CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Basal Cell Carcinoma
Interventions
BIOLOGICAL

Imiquimod and Interferon alpha

Imiquimod first two weeks and last two weeks. Interferon middle five weeks.

Trial Locations (1)

77030

University of Texas Health Science Center of Houston Dermatology Clinic, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT00581425 - Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC) | Biotech Hunter | Biotech Hunter